Thyrocare Technologies Ltd (THYROCARE) Price & Analysis

Compare

0 Followers

THYROCARE Stock Chart & Stats

Day’s Range― - ―

52-Week Range₹658.00 - ₹1,434.30

Previous CloseN/A

Volume114.81K

Average Volume (3M)13.57K

Market Cap

₹67.19B

Enterprise Value₹34.38B

Total Cash (Recent Filing)₹1.93B

Total Debt (Recent Filing)₹246.80M

Price to Earnings (P/E)63.1

Beta0.41

Next Earnings

Oct 29, 2025

EPS EstimateN/A

Last Dividend Ex-Date

Jul 25, 2025

Dividend Yield1.66%

Share Statistics

EPS (TTM)7.35

Shares Outstanding52,994,446

10 Day Avg. Volume10,357

30 Day Avg. Volume13,572

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹1,462.50

Price Target Upside14.44% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Thyrocare Technologies Ltd News

Thyrocare Seeks Shareholder Approval for New Director Appointment via Postal Ballot

Thyrocare Technologies Ltd ( ($IN:THYROCARE) ) has shared an announcement. Thyrocare Technologies Limited has announced a postal ballot...

4d ago

Thyrocare Confirms Compliance with SEBI Regulations for Q1 2025

Thyrocare Technologies Ltd ( ($IN:THYROCARE) ) has issued an announcement. Thyrocare Technologies Limited has announced that, in compliance...

5M ago

Thyrocare Technologies Announces Trading Window Closure

Thyrocare Technologies Ltd ( ($IN:THYROCARE) ) has provided an update. Thyrocare Technologies Ltd has announced the closure of...

5M ago

Thyrocare Expands in Tanzania with Additional Equity Infusion

Thyrocare Technologies Ltd ( ($IN:THYROCARE) ) has shared an update. Thyrocare Technologies Limited has announced an additional equity...

6M ago

THYROCARE FAQ

What was Thyrocare Technologies Ltd’s price range in the past 12 months?

Thyrocare Technologies Ltd lowest stock price was ₹658.00 and its highest was ₹1434.30 in the past 12 months.

What is Thyrocare Technologies Ltd’s market cap?

Thyrocare Technologies Ltd’s market cap is ₹67.19B.

When is Thyrocare Technologies Ltd’s upcoming earnings report date?

Thyrocare Technologies Ltd’s upcoming earnings report date is Oct 29, 2025 which is in 61 days.

How were Thyrocare Technologies Ltd’s earnings last quarter?

Thyrocare Technologies Ltd released its earnings results on Jul 23, 2025. The company reported ₹7.347 earnings per share for the quarter, beating the consensus estimate of ₹5.1 by ₹2.247.

Is Thyrocare Technologies Ltd overvalued?

According to Wall Street analysts Thyrocare Technologies Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Thyrocare Technologies Ltd pay dividends?

Thyrocare Technologies Ltd pays a Annually dividend of ₹21 which represents an annual dividend yield of 1.66%. See more information on Thyrocare Technologies Ltd dividends here

What is Thyrocare Technologies Ltd’s EPS estimate?

Thyrocare Technologies Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Thyrocare Technologies Ltd have?

Thyrocare Technologies Ltd has 52,994,446 shares outstanding.

What happened to Thyrocare Technologies Ltd’s price movement after its last earnings report?

Thyrocare Technologies Ltd reported an EPS of ₹7.347 in its last earnings report, beating expectations of ₹5.1. Following the earnings report the stock price went up 1.5%.

Which hedge fund is a major shareholder of Thyrocare Technologies Ltd?

Currently, no hedge funds are holding shares in IN:THYROCARE

Company Description

Thyrocare Technologies Ltd

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Thyrocare Technologies Ltd (THYROCARE) Earnings & Revenues

Historic Earnings Reports

THYROCARE Stock 12 Month Forecast

Average Price Target

₹1,462.50

▲(14.44% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"583":"₹583","1466":"₹1,466","803.75":"₹803.8","1024.5":"₹1,024.5","1245.25":"₹1,245.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1465,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.47K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1462.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.46K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1460,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.46K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[583,803.75,1024.5,1245.25,1466],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2024","6":"Sep<br/>2024","9":"Dec<br/>2024","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,959.55,998.4307692307692,1037.3115384615385,1076.1923076923076,1115.0730769230768,1153.9538461538461,1192.8346153846153,1231.7153846153847,1270.5961538461538,1309.476923076923,1348.3576923076923,1387.2384615384615,1426.1192307692309,{"y":1465,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,959.55,998.2384615384615,1036.926923076923,1075.6153846153845,1114.303846153846,1152.9923076923076,1191.680769230769,1230.3692307692309,1269.0576923076924,1307.746153846154,1346.4346153846154,1385.123076923077,1423.8115384615385,{"y":1462.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,959.55,998.0461538461539,1036.5423076923078,1075.0384615384614,1113.5346153846153,1152.0307692307692,1190.5269230769231,1229.023076923077,1267.5192307692307,1306.0153846153846,1344.5115384615385,1383.0076923076922,1421.503846153846,{"y":1460,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":656.84,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":584.14,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":620.73,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":590.31,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":627.28,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":788.73,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":826.38,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":814.27,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":923.18,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1020.63,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":907.63,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":907.63,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":959.55,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >